nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—FLT4—VEGFR3 signaling in lymphatic endothelium—COL1A1—otosclerosis	0.0623	0.098	CbGpPWpGaD
Sorafenib—PDGFRA—Osteoblast Signaling—COL1A1—otosclerosis	0.0361	0.0568	CbGpPWpGaD
Sorafenib—MUSK—tendon—otosclerosis	0.0335	0.092	CbGeAlD
Sorafenib—PDGFRB—Osteoblast Signaling—COL1A1—otosclerosis	0.0325	0.0511	CbGpPWpGaD
Sorafenib—MAPK11—VEGFR3 signaling in lymphatic endothelium—COL1A1—otosclerosis	0.0266	0.0418	CbGpPWpGaD
Sorafenib—MAPK11—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.0243	0.0382	CbGpPWpGaD
Sorafenib—CSF1R—Integrins in angiogenesis—COL1A1—otosclerosis	0.0229	0.036	CbGpPWpGaD
Sorafenib—CDK7—connective tissue—otosclerosis	0.0209	0.0573	CbGeAlD
Sorafenib—KDR—Beta3 integrin cell surface interactions—COL1A1—otosclerosis	0.02	0.0315	CbGpPWpGaD
Sorafenib—MUSK—Extracellular matrix organization—COL1A1—otosclerosis	0.0197	0.0309	CbGpPWpGaD
Sorafenib—MUSK—ECM proteoglycans—TGFB1—otosclerosis	0.0196	0.0308	CbGpPWpGaD
Sorafenib—HIPK3—connective tissue—otosclerosis	0.0177	0.0485	CbGeAlD
Sorafenib—FLT1—Focal Adhesion—RELN—otosclerosis	0.0171	0.0268	CbGpPWpGaD
Sorafenib—RAF1—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.0166	0.0262	CbGpPWpGaD
Sorafenib—FLT3—connective tissue—otosclerosis	0.015	0.0412	CbGeAlD
Sorafenib—KDR—Integrins in angiogenesis—COL1A1—otosclerosis	0.0148	0.0232	CbGpPWpGaD
Sorafenib—TAOK2—tendon—otosclerosis	0.0142	0.0391	CbGeAlD
Sorafenib—RET—Dopaminergic Neurogenesis—TGFB1—otosclerosis	0.0142	0.0223	CbGpPWpGaD
Sorafenib—AURKC—tendon—otosclerosis	0.0141	0.0388	CbGeAlD
Sorafenib—PDGFRB—Beta3 integrin cell surface interactions—COL1A1—otosclerosis	0.0132	0.0208	CbGpPWpGaD
Sorafenib—FLT1—Glypican 1 network—TGFB1—otosclerosis	0.0128	0.0201	CbGpPWpGaD
Sorafenib—ZAK—tendon—otosclerosis	0.0124	0.0341	CbGeAlD
Sorafenib—MKNK2—connective tissue—otosclerosis	0.0123	0.0339	CbGeAlD
Sorafenib—HIPK3—tendon—otosclerosis	0.0121	0.0333	CbGeAlD
Sorafenib—RET—connective tissue—otosclerosis	0.012	0.0331	CbGeAlD
Sorafenib—MAP2K5—Focal Adhesion—RELN—otosclerosis	0.0117	0.0183	CbGpPWpGaD
Sorafenib—KDR—Focal Adhesion—RELN—otosclerosis	0.0114	0.0179	CbGpPWpGaD
Sorafenib—BRAF—tendon—otosclerosis	0.0109	0.0299	CbGeAlD
Sorafenib—FLT1—connective tissue—otosclerosis	0.0106	0.0291	CbGeAlD
Sorafenib—RAF1—connective tissue—otosclerosis	0.0105	0.0289	CbGeAlD
Sorafenib—EPHX2—tendon—otosclerosis	0.0104	0.0285	CbGeAlD
Sorafenib—PDGFRA—connective tissue—otosclerosis	0.00994	0.0273	CbGeAlD
Sorafenib—BRAF—Focal Adhesion—RELN—otosclerosis	0.00967	0.0152	CbGpPWpGaD
Sorafenib—FGFR1—tendon—otosclerosis	0.00925	0.0254	CbGeAlD
Sorafenib—FLT1—Focal Adhesion—COL1A1—otosclerosis	0.00917	0.0144	CbGpPWpGaD
Sorafenib—KDR—connective tissue—otosclerosis	0.00896	0.0246	CbGeAlD
Sorafenib—MAP3K7—tendon—otosclerosis	0.00875	0.024	CbGeAlD
Sorafenib—CSF1R—connective tissue—otosclerosis	0.00875	0.024	CbGeAlD
Sorafenib—MKNK2—tendon—otosclerosis	0.00848	0.0233	CbGeAlD
Sorafenib—BRAF—Senescence and Autophagy in Cancer—COL1A1—otosclerosis	0.00835	0.0131	CbGpPWpGaD
Sorafenib—PDGFRA—Focal Adhesion—RELN—otosclerosis	0.00833	0.0131	CbGpPWpGaD
Sorafenib—RET—tendon—otosclerosis	0.00827	0.0227	CbGeAlD
Sorafenib—CSF1R—Differentiation Pathway—TGFB1—otosclerosis	0.00808	0.0127	CbGpPWpGaD
Sorafenib—ZAK—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00801	0.0126	CbGpPWpGaD
Sorafenib—KIT—connective tissue—otosclerosis	0.00794	0.0218	CbGeAlD
Sorafenib—PDGFRB—connective tissue—otosclerosis	0.00776	0.0213	CbGeAlD
Sorafenib—RALBP1—tendon—otosclerosis	0.00766	0.021	CbGeAlD
Sorafenib—PDGFRB—Focal Adhesion—RELN—otosclerosis	0.00751	0.0118	CbGpPWpGaD
Sorafenib—FLT1—tendon—otosclerosis	0.00729	0.02	CbGeAlD
Sorafenib—RAF1—tendon—otosclerosis	0.00725	0.0199	CbGeAlD
Sorafenib—EPHB6—tendon—otosclerosis	0.0072	0.0198	CbGeAlD
Sorafenib—STK10—tendon—otosclerosis	0.0069	0.0189	CbGeAlD
Sorafenib—PDGFRA—tendon—otosclerosis	0.00683	0.0188	CbGeAlD
Sorafenib—TAOK2—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00681	0.0107	CbGpPWpGaD
Sorafenib—RAF1—Focal Adhesion—RELN—otosclerosis	0.00669	0.0105	CbGpPWpGaD
Sorafenib—MAP2K5—Focal Adhesion—COL1A1—otosclerosis	0.00626	0.00985	CbGpPWpGaD
Sorafenib—FGFR1—Glypican 1 network—TGFB1—otosclerosis	0.00626	0.00984	CbGpPWpGaD
Sorafenib—MAP2K5—tendon—otosclerosis	0.00616	0.0169	CbGeAlD
Sorafenib—KDR—tendon—otosclerosis	0.00616	0.0169	CbGeAlD
Sorafenib—KDR—Focal Adhesion—COL1A1—otosclerosis	0.0061	0.0096	CbGpPWpGaD
Sorafenib—CSF1R—tendon—otosclerosis	0.00601	0.0165	CbGeAlD
Sorafenib—RAF1—Senescence and Autophagy in Cancer—COL1A1—otosclerosis	0.00578	0.00909	CbGpPWpGaD
Sorafenib—MUSK—Extracellular matrix organization—TGFB1—otosclerosis	0.00558	0.00878	CbGpPWpGaD
Sorafenib—CDK7—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00549	0.00864	CbGpPWpGaD
Sorafenib—PDGFRB—tendon—otosclerosis	0.00533	0.0146	CbGeAlD
Sorafenib—BRAF—Focal Adhesion—COL1A1—otosclerosis	0.0052	0.00818	CbGpPWpGaD
Sorafenib—KDR—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00481	0.00757	CbGpPWpGaD
Sorafenib—MAP2K5—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00479	0.00754	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—COL1A1—otosclerosis	0.00469	0.00738	CbGpPWpGaD
Sorafenib—PDGFRA—Focal Adhesion—COL1A1—otosclerosis	0.00448	0.00705	CbGpPWpGaD
Sorafenib—RAF1—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—otosclerosis	0.00447	0.00703	CbGpPWpGaD
Sorafenib—ABCC4—tendon—otosclerosis	0.00425	0.0117	CbGeAlD
Sorafenib—HTR2B—tendon—otosclerosis	0.00422	0.0116	CbGeAlD
Sorafenib—ABCC2—tendon—otosclerosis	0.00411	0.0113	CbGeAlD
Sorafenib—KIT—Differentiation Pathway—TGFB1—otosclerosis	0.00404	0.00635	CbGpPWpGaD
Sorafenib—PDGFRB—Focal Adhesion—COL1A1—otosclerosis	0.00404	0.00635	CbGpPWpGaD
Sorafenib—CDK7—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00391	0.00616	CbGpPWpGaD
Sorafenib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—otosclerosis	0.00383	0.00603	CbGpPWpGaD
Sorafenib—MAP3K7—TGF-beta receptor signaling—TGFB1—otosclerosis	0.00379	0.00596	CbGpPWpGaD
Sorafenib—KIT—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00373	0.00587	CbGpPWpGaD
Sorafenib—MAP3K7—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00362	0.0057	CbGpPWpGaD
Sorafenib—RAF1—Focal Adhesion—COL1A1—otosclerosis	0.0036	0.00566	CbGpPWpGaD
Sorafenib—PDGFRA—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00353	0.00555	CbGpPWpGaD
Sorafenib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00342	0.00537	CbGpPWpGaD
Sorafenib—RAF1—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00329	0.00518	CbGpPWpGaD
Sorafenib—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.00326	0.00513	CbGpPWpGaD
Sorafenib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.00326	0.00513	CbGpPWpGaD
Sorafenib—MKNK1—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00319	0.00502	CbGpPWpGaD
Sorafenib—FGFR1—Endochondral Ossification—TGFB1—otosclerosis	0.00304	0.00479	CbGpPWpGaD
Sorafenib—RAF1—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00302	0.00475	CbGpPWpGaD
Sorafenib—RAF1—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00275	0.00433	CbGpPWpGaD
Sorafenib—BRAF—Corticotropin-releasing hormone—TGFB1—otosclerosis	0.00264	0.00415	CbGpPWpGaD
Sorafenib—PDGFRA—Allograft Rejection—TGFB1—otosclerosis	0.00257	0.00404	CbGpPWpGaD
Sorafenib—MAP3K7—TCR Signaling Pathway—TGFB1—otosclerosis	0.00244	0.00384	CbGpPWpGaD
Sorafenib—ABCC4—Platelet degranulation—TGFB1—otosclerosis	0.00243	0.00382	CbGpPWpGaD
Sorafenib—BRAF—Senescence and Autophagy in Cancer—TGFB1—otosclerosis	0.00237	0.00373	CbGpPWpGaD
Sorafenib—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—otosclerosis	0.00231	0.00363	CbGpPWpGaD
Sorafenib—MAP3K7—DNA Damage Response (only ATM dependent)—TGFB1—otosclerosis	0.0021	0.0033	CbGpPWpGaD
Sorafenib—MAP2K5—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00196	0.00309	CbGpPWpGaD
Sorafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00196	0.00309	CbGpPWpGaD
Sorafenib—RAF1—TCR Signaling Pathway—TGFB1—otosclerosis	0.00186	0.00292	CbGpPWpGaD
Sorafenib—RAF1—Corticotropin-releasing hormone—TGFB1—otosclerosis	0.00182	0.00287	CbGpPWpGaD
Sorafenib—MAP3K7—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.0018	0.00283	CbGpPWpGaD
Sorafenib—RAF1—Senescence and Autophagy in Cancer—TGFB1—otosclerosis	0.00164	0.00258	CbGpPWpGaD
Sorafenib—BRAF—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00163	0.00256	CbGpPWpGaD
Sorafenib—ABCC4—NRF2 pathway—TGFB1—otosclerosis	0.0015	0.00236	CbGpPWpGaD
Sorafenib—MAP3K7—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00148	0.00233	CbGpPWpGaD
Sorafenib—FGFR1—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00141	0.00221	CbGpPWpGaD
Sorafenib—RAF1—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.00137	0.00215	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—TGFB1—otosclerosis	0.00133	0.00209	CbGpPWpGaD
Sorafenib—EPHB6—Developmental Biology—TGFB1—otosclerosis	0.00132	0.00208	CbGpPWpGaD
Sorafenib—UGT1A1—NRF2 pathway—TGFB1—otosclerosis	0.0013	0.00204	CbGpPWpGaD
Sorafenib—UGT1A9—NRF2 pathway—TGFB1—otosclerosis	0.0013	0.00204	CbGpPWpGaD
Sorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.00127	0.002	CbGpPWpGaD
Sorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.00127	0.00199	CbGpPWpGaD
Sorafenib—ABCC2—NRF2 pathway—TGFB1—otosclerosis	0.00126	0.00199	CbGpPWpGaD
Sorafenib—PDGFRB—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00126	0.00199	CbGpPWpGaD
Sorafenib—EPHA6—Developmental Biology—TGFB1—otosclerosis	0.00124	0.00195	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.0012	0.00188	CbGpPWpGaD
Sorafenib—RAF1—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00113	0.00177	CbGpPWpGaD
Sorafenib—ABCC4—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.00108	0.00169	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.00102	0.0016	CbGpPWpGaD
Sorafenib—ABCB1—Allograft Rejection—TGFB1—otosclerosis	0.000972	0.00153	CbGpPWpGaD
Sorafenib—RAF1—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000905	0.00142	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—TGFB1—otosclerosis	0.000807	0.00127	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—TGFB1—otosclerosis	0.000694	0.00109	CbGpPWpGaD
Sorafenib—MKNK1—Disease—TGFB1—otosclerosis	0.000639	0.00101	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—TGFB1—otosclerosis	0.000594	0.000934	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—TGFB1—otosclerosis	0.000555	0.000872	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—TGFB1—otosclerosis	0.000549	0.000864	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—TGFB1—otosclerosis	0.00054	0.00085	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000479	0.000754	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—TGFB1—otosclerosis	0.000475	0.000748	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—TGFB1—otosclerosis	0.000466	0.000733	CbGpPWpGaD
Sorafenib—CDK7—Disease—TGFB1—otosclerosis	0.00045	0.000709	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—TGFB1—otosclerosis	0.000448	0.000704	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—TGFB1—otosclerosis	0.000403	0.000634	CbGpPWpGaD
Sorafenib—BRAF—Disease—TGFB1—otosclerosis	0.000326	0.000513	CbGpPWpGaD
Sorafenib—KIT—Disease—TGFB1—otosclerosis	0.000297	0.000467	CbGpPWpGaD
Sorafenib—FGFR1—Disease—TGFB1—otosclerosis	0.000282	0.000443	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—TGFB1—otosclerosis	0.000281	0.000442	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—TGFB1—otosclerosis	0.000275	0.000433	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—TGFB1—otosclerosis	0.000268	0.000422	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—TGFB1—otosclerosis	0.000253	0.000398	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TGFB1—otosclerosis	0.000231	0.000363	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TGFB1—otosclerosis	0.000229	0.000359	CbGpPWpGaD
Sorafenib—RAF1—Disease—TGFB1—otosclerosis	0.000226	0.000355	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TGFB1—otosclerosis	0.000208	0.000327	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TGFB1—otosclerosis	0.000208	0.000327	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TGFB1—otosclerosis	0.000197	0.00031	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TGFB1—otosclerosis	0.000197	0.00031	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TGFB1—otosclerosis	0.000177	0.000279	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TGFB1—otosclerosis	0.000169	0.000266	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TGFB1—otosclerosis	0.000158	0.000249	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TGFB1—otosclerosis	0.000136	0.000215	CbGpPWpGaD
